Skip to main content
. 2022 Jan 18;20:12. doi: 10.1186/s12916-021-02207-x

Table 6.

Improvement in ECOG after the treatment of alectinib

Patients with CNS-related symptoms in the baseline, n = 28 Number of patients
No improvement in ECOG after the treatment of alectinib 8 (28.6%)
ECOG was improved by 1 point after the treatment of alectinib 14 (50%)
ECOG was improved by 2 points after the treatment of alectinib 6 (21.4%)